With Brexit uncertainty still ongoing, businesses look forward and focus on growth

For the past three years, we have witnessed a carousel of Brexit-related ups and downs. Endless trips to Brussels and votes in Parliament have exhausted not only politicians but also the British people and business people who need to keep on working on shaky territory.

In the latest episode of FinancialFox, James Bevan, asset manager and Chief Investment Officer at CCLA shared his insights about Britain’s divorce from the EU, and the post-scenario for the UK and business.

James Bevan talks to PR Guru Stefania Barbaglio in the latest episode of FinancialFox.

Having been in the public sector for many years, James Bevan shares valuable insights about finance, investment, technology, employment and opportunities. He believes that despite diverging views on how to handle Brexit, an orderly exit with a deal is still the best option, as agreed by the majority of Members of Parliament. “I believe a positive deal with the EU might lead to a significant pick-up of investments. I don’t think it is fanciful to suggest that in 2020, the UK could be the fastest growing economy in the G7.”

Nevertheless, there are many challenges which could hinder such growth. James points out that the UK economy is largely reliant on the services sector, and if Britain wants to keep its competitive edge on the global stage, it has to increase internal productivity and entrepreneurship.

In practical terms, the uncertainty around how post-Brexit Britain would look is the same now as it was three years ago. Much has been said about the slowing of the economy as an immediate result of Brexit. Analysts do 2019 to be slow in terms of activity; growth should pick up again next year. According to PwC’s UK Economic Outlook report released in March, UK growth is to dip to 1.1% in 2019 and to strengthen only moderately, to 1.6% in 2020.

Data from PwC UK Economic Outlook March 2019

Fintech continues to boom

While no decisions are made in Westminster and political battles make for a gloomy outlook, in the City of London ̶ and more specifically in Shoreditch’s Tech City ̶ businesses continue to flourish.

Fintech is indeed one of the gems of the British finance sector, and rightly so: in the first six months of 2018 alone, the UK attracted a record high £12bn of investment in Fintech. London is quickly catching up with San Francisco, the global capital of fintech. City AM reported that, among the 29 fintech unicorns ̶ companies with a valuation of more than $1bn ̶ nine are in San Francisco, while seven are based in the UK capital. Last year, London received more than a third of the European fintech venture capital funding.

Will this trend continue to point upwards after Brexit? Some experts think so, as investments in digital banking projects continue to pour in in 2019. According to QZ, the chief executives of the payment app and fintech unicorn Revolut, and Clausematch, a compliance company, get five to six calls from investors each week. Revolut CEO Nikolay Storonsky claimed that Revolut may look to raise $500 million or even more in 2019 as the company’s valuation increases.

Data from Quartz, February 2019

Anne Boden, CEO of digital banking platform Starling Bank, says the positive outlook on UK’s fintech can be attributed to the uniqueness of the companies, and that not many new projects are being licenced.

Trade and New Partnerships

One of the main arguments of Brexiteers is that, once outside the EU, the UK would have more autonomy over its trade agreements and commerce partners. In the technology sector, we see that the UK has proactively looked for partners outside the European bloc. Closer relationships with emerging markets are particularly positive in this scenario, given the rapid growth of their digital economies and the market opportunities posed for fintech companies based in Britain.

International partnerships are crucial, given that most the UK’s trade agreements nowadays happen within the EU, rather than outside. In a quest to widen its outreach, British officials have started talks with other countries.

In March, leading members of the Thailand and Vietnam Fintech communities were in London to visit world-leading Fintech businesses.

“As we leave the EU, the UK is working harder than ever to build Fintech partnerships with others. We have put Fintech at the heart of the UK’s ASEAN Economic Reform Programme, which will focus on Southeast Asia and which aims to promote inclusive economic growth. This three-year programme will provide technical assistance and the opportunity to share experiences in support of the continuing development of Fintech regulation in Thailand, Vietnam and some other ASEAN countries,” said MP Mark Field about the deepening relationship with nations in Southeast Asia.

Cassiopeia presents: CargoCoin

Cassiopeia Services, the boutique IR/PR agency leading the blockchain revolution is thrilled to announce CargoCoin as the fourth confirmed company presenting at our Symposium on Wednesday 21st November at the May Fair Hotel.

CargoCoin is revolutionising global trade and transport by implementing decentralised technologies into the supply chain. The company links the physical world of trade, transport and logistics with the blockchain by replacing paper documents with smart contracts and providing secure escrow payments throughout the process. Incorporating blockchain into the supply chain means stronger ethics, more sustainability and better consumer protection.

A supply chain encompasses many levels, from manufacturing to consumer use and multiple actors in between: producers, shippers, warehouses and governments to name only a few. The current globalised manufacturing system implies that these typically complex supply chains actually surpass geographical boundaries, sometimes intercontinentally. In the current model, this results in a lack of transparency. Consumers have limited knowledge and understanding of the manufacturing process, allowing flaws and discrepancies to go unnoticed by the public eye.

An open-sourced traceable supply-chain can help tackle problems like Payment Cycle, cybersecurity and Fraud Prevention by establishing a trust protocol, as records are inalterable and cannot be deleted. Furthermore, an integrated system is likely to reduce the time and costs involved in the process. It is estimated that costs of trade-related paperwork amount to about 15 to 20 percent of transport expenditure. With blockchain, key quality indicators can be recorded from IoT devices from each point of the product’s journey, lowering fees, which ultimately results in cost savings.

Joshua Alexander, investment advisor and cyber security auditor, will be presenting Cargo Coin this Wednesday at our symposium.

About Cassiopeia Investor Symposia

The Cassiopeia Symposia series are exclusive events for selected companies and investors to network in an informal and friendly setting. We facilitate connections and an ongoing dialogue between companies and market opinion leaders.

At the end of each presentation, investors will have the opportunity to ask the management team questions during a Q&A session, after which a fine selection of drinks and canapes will be offered to all our guests.

In addition to CargoCoin, we will introduce guests to Andalas Energy, an AIM-listed company which has been in the spotlight recently over its newly-acquired assets in the North Sea as well as its positioning in Indonesia; and Right of Reply, an innovative technology company with a flagship blockchain-powered platform for online reputation management, coming soon onto the LSE market. We will also hear from the developers of Neurotrader, a software application designed to maximise trading performance and generate consistent rates of returns to investors.

You can watch presentations from the previous symposia and exclusive interviews with CEOs on our YouTube channel here

REGISTER https://www.eventbrite.co.uk/e/cassiopeia-investor-symposium-tickets-47398735895

NeuroTrader: Harnessing biodata to optimise real-time trading performance

There are many factors one should consider before making decisions in the trading process. Whereas research about company performance, market outlook and stock trends are certainly important, there is also a psychological element that is very often overlooked by investors, which holds them back from gaining better returns from their trading activities.

Trading activity, often assumed to be based on logical and analytical behaviour in order to balance out the inherent risk and possible gains, is often strongly impacted by the trader’s state of mind. Stress, excitement and overstimulation are among the many variables which can lead to risky trading decisions and potential losses. The forces affecting trading decisions are indeed multifactorial but directly impact the outcomes.

Very often, financial losses can be attributed to poor decision making arising from fear, trepidation and anxiety, each of which show specific biological patterns. When investors get too emotionally involved with trading, they are more apt to take greater risks, which quite possibly lead to less favourable returns. Financial gains, on the other hand, tend to result from clarity and optimism, which have their own biological patterns, better known as “biomarkers”.

Emotions such as fear and greed are common in a trader’s daily life. Stocks and markets are, after all, fluid systems and bad news is bound to crop up. however, these emotions are misleading and as result, compromise trading performance. In order to ensure better results, traders should discipline themselves to override their instincts and move past the emotional response. This reflects on the figures; only 5% of traders make a profit at the end of the year.A reliable solution to prevent emotions from hindering optimal trading performance is a tool which provides insights into the trader’s neurosystem, informing smarter decisions. But is there such a solution without resorting to algorithms or robots?

NeuroTrader is a suite of software applications which can enhance traders’ decision-making effectiveness with wearable technology. Based on the concept of trading as a peak performance sport, NeuroTrader is creating the science of optimal decision making.

Real-time monitoring of the traders and their biodata provides an opportunity to mitigate risk, optimise performance and create stable and consistent rates of return as a function of the traders’ biological responses to price and market sentiment.

NeuroTrader is the system to help investors make better choices based on clinical analysis and objectivity. By analysing biodata collected via wearable technology, NeuroTrader can discern different human performance states and therefore inform trading decisions based upon the biological state of the trader, providing an advanced risk-management tool for every trade.

Neurotrader is initiating its pilot program in February next year, in which it will be monitoring 100 traders globally over a 6-month period. The NeuroTrader team, with 10 years of research and testing in the field, expect the platform to mitigate on average 20% of trading errors.

The industry has already taken the route of eliminating humans from trading and using machine learning to improve trading results, but the problem for financial institutions is that they have misunderstood the limitations of these technologies.

“There is a perfect middle ground where machines assist human performance; this is a paradigm-shift where machines serve people to achieve greater heights, not to make them redundant,” says Ken Medanic, the creator and founder of NeuroTrader.

NeuroTrader promises to be one of the first technologies to improve behavioural patterns in trading activity — suitable for both individuals and institutional investors. Hear more about this exciting tool in person. Don’t miss NeuroTrader’s presentation at Cassiopeia Investor Symposium! Register here

NeuroTrader: Harnessing biodata to optimise real-time trading performance

There are many factors one should consider before making decisions in the trading process. Whereas research about company performance, market outlook and stock trends are certainly important, there is also a psychological element that is very often overlooked by investors, which holds them back from gaining better returns from their trading activities.

Trading activity, often assumed to be based on logical and analytical behaviour in order to balance out the inherent risk and possible gains, is often strongly impacted by the trader’s state of mind. Stress, excitement and overstimulation are among the many variables which can lead to risky trading decisions and potential losses. The forces affecting trading decisions are indeed multifactorial but directly impact the outcomes.

Very often, financial losses can be attributed to poor decision making arising from fear, trepidation and anxiety, each of which show specific biological patterns. When investors get too emotionally involved with trading, they are more apt to take greater risks, which quite possibly lead to less favourable returns. Financial gains, on the other hand, tend to result from clarity and optimism, which have their own biological patterns, better known as “biomarkers”.

Emotions such as fear and greed are common in a trader’s daily life. Stocks and markets are, after all, fluid systems and bad news is bound to crop up. however, these emotions are misleading and as result, compromise trading performance. In order to ensure better results, traders should discipline themselves to override their instincts and move past the emotional response. This reflects on the figures; only 5% of traders make a profit at the end of the year.A reliable solution to prevent emotions from hindering optimal trading performance is a tool which provides insights into the trader’s neurosystem, informing smarter decisions. But is there such a solution without resorting to algorithms or robots?

NeuroTrader is a suite of software applications which can enhance traders’ decision-making effectiveness with wearable technology. Based on the concept of trading as a peak performance sport, NeuroTrader is creating the science of optimal decision making.

Real-time monitoring of the traders and their biodata provides an opportunity to mitigate risk, optimise performance and create stable and consistent rates of return as a function of the traders’ biological responses to price and market sentiment.

NeuroTrader is the system to help investors make better choices based on clinical analysis and objectivity. By analysing biodata collected via wearable technology, NeuroTrader can discern different human performance states and therefore inform trading decisions based upon the biological state of the trader, providing an advanced risk-management tool for every trade.

Neurotrader is initiating its pilot program in February next year, in which it will be monitoring 100 traders globally over a 6-month period. The NeuroTrader team, with 10 years of research and testing in the field, expect the platform to mitigate on average 20% of trading errors.

The industry has already taken the route of eliminating humans from trading and using machine learning to improve trading results, but the problem for financial institutions is that they have misunderstood the limitations of these technologies.

“There is a perfect middle ground where machines assist human performance; this is a paradigm-shift where machines serve people to achieve greater heights, not to make them redundant,” says Ken Medanic, the creator and founder of NeuroTrader.

NeuroTrader promises to be one of the first technologies to improve behavioural patterns in trading activity — suitable for both individuals and institutional investors. Hear more about this exciting tool in person. Don’t miss NeuroTrader’s presentation at Cassiopeia Investor Symposium! Register here

Cassiopeia Investor Symposium: Autumn 2018

Following on from the success of our previous symposia, the Cassiopeia team is back with our Autumn Symposium. We’ll be at the Mayfair Hotel in central London with exciting companies to watch out for. Save the date: 21st November 2018 from 6.30 pm.

Whether you’re a shareholder, investor or trader and regardless of your level of experience or strategy, the ethos of our symposia is to create an opportunity for investors to meet company directors and get actively involved in sourcing information. We facilitate connections and an ongoing dialogue between companies and market opinion leaders. Information is key to investment and trading.

The Cassiopeia Symposia series are exclusive events, only for selected companies and investors to network in an informal and friendly setting.

Investors are welcome to attend the presentations in what will be an relaxed atmosphere where they can meet company managers face to face and network with other existing shareholders or investors to discuss company strategy, plans, developments and value.

In this edition, we will introduce guests to Andalas Energy, an AIM-listed company which has been in the spotlight recently over its newly-acquired assets in the North Sea as well as their positioning in Indonesia; and Right of Reply, an innovative technology company with a flagship blockchain-powered platform for online reputation management, coming soon onto the LSE market.

We will also hear from the developers of Neurotrader, a software application designed to maximise trading performance and generate consistent rates of returns to investors.

At the end of each presentation, investors will have the opportunity to ask the management team questions during a Q&A session moderated by multi-awarded winning ADVFN International Financial Blogger Daniel Levi, aka the Infamous BrokermanDan.

Opinion leaders, market influencers and well-known City traders regularly attend our events.

Presenting companies:

Andalas Energy (LSE: ADL) is an AIM-listed Oil & Gas company with an international energy business focused on developing upstream assets, applying innovative solutions to generate revenue. Andalas is in partnership to develop a series of wellhead IPPs in Indonesia, and more recently acquired assets in the North Sea, while currently in discussion on new projects with a third party in Indonesia. Under new management, Andalas is operating with a fresh strategy and is committed to delivering value to its shareholders. Visit Andalas website for more information: http://www.andalasenergy.co.uk

Right of Reply (RoR) is an innovative Social Impact Technology company providing rapid, low-cost and legally sound solutions to individuals and enterprises to help manage their online reputations. With a fresh approach to a growing problem, RoR ensures everyone’s ability to counter unfair, inaccurate or incorrect content with timeliness and relevance. RoR offers platforms for regulated media, products for credit checking and scoring, as well as services for digital identity and social media. Visit Right of Reply website for more information: https://rightofreply.news

Neurotrader is a suite of software applications to enhance the decision-making effectiveness of the trader through the use of wearable technology. Based on the concept of trading as a peak performance sport, NeuroTrader is creating the science of optimal decision making for traders globally. Monitoring the trader and its biodata in real-time, it provides the opportunity to effectively mitigate risk and optimize performance and create stable, consistent rates of return as a function of their biological responses to price and market sentiment. Where performance is measured, monitored and managed. For more information on how to gain your trading competitive advantage, please visit NeuroTrader webiste: https://neurotrader.com

You can watch presentations from the previous symposia and exclusive interviews with CEOs on our YouTube channel here

A fine selection of drinks and canapes will be offered to all our guests. An evening you can’t miss!

Register here See you in November!